Clinical trialNCT06849973CompletedPhase 2/PHASE3Interventional

To Study the Efficacy & Safety of Oral NA-921 (Bionetide) in Girls and Women with Rett Syndrome

SponsorBiomed Industries, Inc.Enrollment187Rett Syndrome

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To study the efficacy \& safety of oral Bionetide versus placebo in girls and women with Rett syndrome

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

David Nguyen, PhD
Biomed Industries, Inc.
Study Director
clinicaltrials.gov ↗
Lloyd L. Tran, PhD
Biomed Industries, Inc.
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Biomed Research Unit-Bio-16-Nsw
Camperdown, New South Wales, Australia
Biomed Research Unit-Bio-15
Sydney, New South Wales, Australia
Biomed Research Unit-Bio-13-Vic-3084 Heidelberg West, Victoria, Australia, 3084
Heidelberg West, Victoria, Australia
Biomed Research Unit- Bio-14-Vic 3010
Parkville, Victoria, Australia

United States

Biomed Testing Facility # Bio-04-92093
La Jolla, California, United States
Biomed Testing Facility # Bio-03-90095
Los Angeles, California, United States
Biomed Testing Facility # Bio-02-95817
Sacramento, California, United States
Biomed Testing Facility # Bio-01-94104
San Francisco, California, United States
Biomed Testing Facility #bio-05-80042
Aurora, Colorado, United States
Biomed Testing Facility #bio-06-60612
Chicago, Illinois, United States
Maryland Locations Biomed Testing Facility #bio-7-21205
Baltimore, Maryland, United States
Biomed Testing Facility #bio-8-02115
Boston, Massachusetts, United States
Biomed Testing Facility #bio-9-10467
The Bronx, New York, United States
Biomed Testing Facility #bio-10-44195
Cleveland, Ohio, United States
Biomed Testing Facility #bio-11-77030
Houston, Texas, United States
Biomed Testing Facility #bio-12-98105
Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Drug: BionetidePlacebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 15 Mar 2024
Primary completion: 22 Nov 2024
Completion: 28 Jan 2025
Last update posted: 27 Feb 2025
Registered enrollment: 187
Registry id: NCT06849973

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.